NTES-S
09999
JD HEALTH
06618
TRIP.COM-S
09961
JD-SW
09618
BILIBILI-W
09626
(FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | (Q6)Dec 31, 2020 | (FY)Jun 30, 2020 | (Q6)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -26.10%8.82B | -22.75%4.95B | -23.52%11.93B | -41.30%6.41B | -36.56%15.6B | 165.09%10.91B | 314.27%24.59B | 28.89%4.12B | -26.37%5.93B | -30.91%3.19B |
Operating income | -26.10%8.82B | -22.75%4.95B | -23.52%11.93B | -41.30%6.41B | -36.56%15.6B | 165.09%10.91B | 314.27%24.59B | 28.89%4.12B | -26.37%5.93B | -30.91%3.19B |
Cost of sales | 17.54%-5.38B | 16.42%-3.03B | 11.01%-6.52B | 32.60%-3.62B | 33.60%-7.33B | -181.29%-5.38B | -346.93%-11.04B | -45.51%-1.91B | 30.43%-2.47B | 45.16%-1.31B |
Operating expenses | 17.54%-5.38B | 16.42%-3.03B | 11.01%-6.52B | 32.60%-3.62B | 33.60%-7.33B | -181.29%-5.38B | -346.93%-11.04B | -45.51%-1.91B | 30.43%-2.47B | 45.16%-1.31B |
Gross profit | -36.43%3.44B | -30.99%1.92B | -34.62%5.41B | -49.75%2.78B | -38.97%8.27B | 151.05%5.54B | 290.99%13.54B | 17.29%2.21B | -23.18%3.46B | -15.58%1.88B |
Administrative expenses | 2.75%-885M | 1.84%-486.23M | -3.22%-910M | 0.19%-495.35M | -6.06%-881.59M | -21.09%-496.3M | 2.27%-831.19M | 12.28%-409.85M | 9.60%-850.52M | 15.84%-467.22M |
Profit from asset sales | ---- | 74.74%281.34K | ---- | -84.63%161K | -76.82%4M | -87.42%1.05M | -90.37%17.27M | -93.06%8.33M | 41.28%179.29M | 171.80%119.99M |
Revaluation surplus | -209.78%-202M | 273.38%18.54M | 128.15%184M | 88.15%-10.69M | -18.57%-653.65M | 83.10%-90.21M | 72.79%-551.27M | -418.77%-533.72M | -203.00%-2.03B | -73.65%167.43M |
-Changes in the fair value of investment property | -207.82%-193M | 225.57%17.98M | 126.20%179M | 83.68%-14.32M | -23.26%-683.17M | 83.59%-87.76M | 72.57%-554.23M | -415.85%-534.85M | -202.81%-2.02B | -73.36%169.34M |
-Changes in the fair value of financial assets | -280.00%-9M | -84.85%550.4K | -83.06%5M | 247.94%3.63M | 897.32%29.52M | -318.15%-2.46M | 161.27%2.96M | 159.13%1.13M | -519.94%-4.83M | -620.82%-1.9M |
Operating interest expense | ---- | -0.81%-54.82M | ---- | -72.72%-54.38M | ---60.98M | 36.35%-31.48M | ---- | 36.16%-49.46M | ---- | -33.79%-77.47M |
Special items of operating profit | -201.32%-455M | 114.62%1.2B | -149.35%-151M | 292.18%559.17M | 479.43%305.96M | -77.63%142.58M | -829.20%-80.64M | 21.93%637.24M | 110.59%11.06M | 102.06%522.63M |
Operating profit | -58.17%1.89B | -6.59%2.6B | -35.13%4.53B | -45.06%2.78B | -42.30%6.98B | 172.46%5.06B | 1,454.37%12.1B | -13.40%1.86B | -86.00%778.37M | -15.94%2.15B |
Financing income | 67.25%2.38B | ---- | --1.42B | ---- | ---- | ---- | -44.24%572.89M | ---- | 59.19%1.03B | ---- |
Financing cost | 0.98%-101M | ---- | ---102M | ---- | ---- | ---- | 37.92%-93.58M | ---- | -1.97%-150.76M | ---- |
Share of profits of associates | 44.27%466M | 1,292.78%292.3M | -17.29%323M | -94.71%20.99M | -37.52%390.51M | 385.73%396.65M | -31.38%625.01M | -91.38%81.66M | -33.90%910.89M | 13.66%947.79M |
Share of profit from joint venture company | -71.36%173M | -36.65%72.67M | 1,057.20%604M | 177.33%114.72M | 73.01%-63.1M | -57.97%-148.34M | 50.54%-233.76M | -2,907.89%-93.9M | -318.34%-472.67M | -103.28%-3.12M |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | -67.45%35.09M | ---- | 44.74%107.79M | ---- |
Earning before tax | -29.03%4.81B | 1.57%2.96B | -7.32%6.77B | -45.08%2.92B | -43.80%7.31B | 187.72%5.31B | 490.83%13B | -40.26%1.85B | -71.51%2.2B | -11.23%3.09B |
Tax | 39.75%-520M | 27.34%-330.06M | 36.12%-863M | 51.40%-454.24M | 46.63%-1.35B | -62.43%-934.69M | -379.92%-2.53B | -86.55%-575.45M | 26.37%-527.49M | 11.02%-308.46M |
After-tax profit from continuing operations | -27.46%4.29B | 6.90%2.63B | -0.79%5.91B | -43.73%2.46B | -43.12%5.96B | 244.44%4.38B | 525.80%10.47B | -54.32%1.27B | -76.12%1.67B | -11.26%2.78B |
Earning after tax | -27.46%4.29B | 6.90%2.63B | -0.79%5.91B | -43.73%2.46B | -43.12%5.96B | 244.44%4.38B | 525.80%10.47B | -54.32%1.27B | -76.12%1.67B | -11.26%2.78B |
Minority profit | -32.18%1.78B | 6.43%1.17B | -6.24%2.62B | -46.89%1.09B | -45.87%2.8B | 256.31%2.06B | 569.65%5.17B | -55.18%578.5M | -76.57%771.74M | -12.26%1.29B |
Profit attributable to shareholders | -23.70%2.51B | 7.27%1.47B | 4.04%3.29B | -40.92%1.37B | -40.45%3.16B | 234.52%2.32B | 488.27%5.3B | -53.58%692.59M | -75.72%901.78M | -10.38%1.49B |
Dividend | 3.05%912M | 2.97%315.73M | 5.05%885M | 2.59%306.64M | 6.16%842.46M | 10.94%298.91M | 2.27%793.54M | 2.26%269.42M | 2.21%775.92M | 2.18%263.46M |
Basic earnings per share | -25.47%1.2 | 4.41%0.71 | 0.63%1.61 | -42.86%0.68 | -42.24%1.6 | 230.56%1.19 | 477.08%2.77 | -55.00%0.36 | -76.35%0.48 | -12.09%0.8 |
Diluted earnings per share | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | KPMG | -- | KPMG | -- | KPMG | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.